Acute fulminant hepatitis e virus genotype 3e infection: Description of the first case in Europe

Scandinavian Journal of Infectious Diseases

Volumn 46, Issue 10, 2014, Pages 727-731

  Festa, Stefano ^a   Garbuglia, Anna Rosa ^b   Baccini, Flavia ^a   Panzuto, Francesco ^a   Capobianchi, Maria Rosaria ^b   Santino, Iolanda ^c   Purchiaroni, Flaminia ^a   Orgera, Gianluigi ^a   Delle Fave, Gianfranco ^a   Marignani, Massimo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c Department of Clinical and Molecular Medicine School of Medicine and Psychology   (Italy)

Author keywords

Epidemiology; Fulminant; Genotype; Hepatitis E virus; Phylogenetic tree; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; RIBAVIRIN; VIRUS RNA;

ABDOMINAL AORTA ANEURYSM; ABDOMINAL DISCOMFORT; ACUTE LIVER FAILURE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC THERAPY; AORTA PROSTHESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CULTURAL ANTHROPOLOGY; DISEASE DURATION; ECHOGRAPHY; END STAGE LIVER DISEASE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENERAL CONDITION DETERIORATION; GENETIC ANALYSIS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HEPATOMEGALY; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; INTERNATIONAL NORMALIZED RATIO; ITALY; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION TEST; MALE; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PATIENT HISTORY OF SURGERY; PLEURA EFFUSION; PNEUMONIA; PORTAL VEIN; PROTHROMBIN TIME; RISK FACTOR; SPLENOMEGALY; STEATOSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; URINE COLOR; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; PHYLOGENY; VIROLOGY;

AGED; CLUSTER ANALYSIS; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; ITALY; MALE; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 84907156430     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2014.928417     Document Type: Article

References (22)

1. Pérez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect Genet Evol 2014; 13:40-59.
2. Acharya SK, Panda SK. Hepatitis E:water, water everywhere-now a global disease. J Hepatol 2011; 54:9-11.
3. Suzuki K, Aikawa T, Okamoto H. Fulminant hepatitis E in Japan. N Engl J Med 2002; 347:1456.
4. Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, Cunningham R, et al. Non-travel-associated hepatitis E in England and Wales:demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005; 192:1166-72.
5. Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369:1260.
6. Inoue J, Ueno Y, Nagasaki F, Akahane T, Fukushima K, Kogure T, et al. Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan. J Gastro-enterol 2009; 44:329-37.
7. Romanò L, Paladini S, Tagliacarne C, Canuti M, Bianchi S, Zanetti AR. Hepatitis E in Italy:a long-term prospective study. J Hepatol 2011; 54:34-40.
8. Peron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in Western patients with underlying chronic liver disease:a role for ribavirin? J Hepatol 2011; 54:1323-4.
9. Garbuglia AR, Scognamiglio P, Petrosillo N, Mastroianni CM, Sordillo P, Gentile D, et al. Hepatitis E virus genotype 4 outbreak, Italy, 2011. Emerg Infect Dis 2013; 19:110-4.
10. Nakano T, Okano H, Kobayashi M, Ito K, Ohmori S, Nomura T, et al. Molecular epidemiology and genetic history of European-type genotype 3 hepatitis E virus indi-genized in the central region of Japan. Infect Genet Evol 2012; 12:1524-34.
11. La Rosa G, Muscillo M, Vennarucci VS, Garbuglia AR, La Scala P, Capobianchi MR. Hepatitis E virus in Italy:molecular analysis of travel-related and autochthonous cases. J Gen Virol 2011; 92:1617-26.
12. Kumar AS, Kumar SP, Singh R, Kumar MS, Madan K, Kumar JJ, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007; 46:387-94.
13. Haïm-Boukobza S, Ferey MP, Vétillard AL, Jeblaoui A, Pélissier E, Pelletier G, et al. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012; 57:1374-8.
14. Doudier B, Vencatassin H, Aherfi S, Colson P. Fatal fulminant hepatitis E associated with autoimmune hepatitis and excessive paracetamol intake in southeastern France. J Clin Microbiol 2014; 52:1294-7.
15. Nakano T, Takahashi K, Arai M, Okano H, Kato H, Ayada M, et al. Identifi cation of European-type hepatitis E virus subtype 3e isolates in Japanese wild boars:molecular tracing of HEV from swine to wild boars. Infect Genet Evol 2013; 18:287-98.
16. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202:825-34.
17. Abbas Z, Afzal R. Hepatitis E:when to treat and how to treat. Antivir Ther 2014; 19:125-31.
18. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenterology 2010; 139:1612-8.
19. Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011; 52:60-2.
20. Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK. Ribavirin therapy for hepatitis E virus-induced acute-on-chronic liver failure:a preliminary report. Antivir Ther 2012; 17:1091-6.
21. Pischke S, Hardtke S, Bode U, Birkner U, Chatzikyrkou C, Kauffmann, et al. Ribavirin treatment of acute and chronic hepatitis E:a single-centre experience. Liver Int 2013; 33:722-6.
22. Debing Y, Emerson SU, Wang Y, Pan Q, Balzarini J, Dallmeier K, et al. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interpheron. Antimicrob Agents Chemother 2014; 58:267-73.